School of Medicine
Showing 511-520 of 635 Results
-
Matthew Porteus
Sutardja Chuk Professor of Definitive and Curative Medicine
BioDr. Porteus was raised in California and was a local graduate of Gunn High School before completing A.B. degree in “History and Science” at Harvard University where he graduated Magna Cum Laude and wrote an thesis entitled “Safe or Dangerous Chimeras: The recombinant DNA controversy as a conflict between differing socially constructed interpretations of recombinant DNA technology.” He then returned to the area and completed his combined MD, PhD at Stanford Medical School with his PhD focused on understanding the molecular basis of mammalian forebrain development with his PhD thesis entitled “Isolation and Characterization of TES-1/DLX-2: A Novel Homeobox Gene Expressed During Mammalian Forebrain Development.” After completion of his dual degree program, he was an intern and resident in Pediatrics at Boston Children’s Hospital and then completed his Pediatric Hematology/Oncology fellowship in the combined Boston Chidlren’s Hospital/Dana Farber Cancer Institute program. For his fellowship and post-doctoral research he worked with Dr. David Baltimore at MIT and CalTech where he began his studies in developing homologous recombination as a strategy to correct disease causing mutations in stem cells as definitive and curative therapy for children with genetic diseases of the blood, particularly sickle cell disease. Following his training with Dr. Baltimore, he took an independent faculty position at UT Southwestern in the Departments of Pediatrics and Biochemistry before again returning to Stanford in 2010 as an Associate Professor. During this time his work has been the first to demonstrate that gene correction could be achieved in human cells at frequencies that were high enough to potentially cure patients and is considered one of the pioneers and founders of the field of genome editing—a field that now encompasses thousands of labs and several new companies throughout the world. His research program continues to focus on developing genome editing by homologous recombination as curative therapy for children with genetic diseases but also has interests in the clonal dynamics of heterogeneous populations and the use of genome editing to better understand diseases that affect children including infant leukemias and genetic diseases that affect the muscle. Clinically, Dr. Porteus attends at the Lucille Packard Children’s Hospital where he takes care of pediatric patients undergoing hematopoietic stem cell transplantation.
-
Ellen Porzig
Professor (Teaching) of Developmental Biology, Emerita
Current Research and Scholarly InterestsEarly Human Developmental Biology:
From Egg to Embryo
Organogenesis: Pattern formation
Sex Determination in Embryogenesis -
Klaus Porzig
Emeritus Adjunct Clinical Professor, Medicine - Oncology
BioKlaus Porzig is an Emeritus Adjunct Clinical Professor at Stanford. He was active in Stanford’s clinical oncology program from 1979 until 2008. He was an Attending Physician on the Oncology inpatient service (MED III initially and then MED X) annually from 1979 until retirement in 2008. He was active in the breast cancer program during those decades. Dr. Porzig was a founding partner in South Bay Oncology in 1979 which became part of the Stanford Cancer Center in the Southbay after his retirement. He was a member of the council of the California Breast Cancer Research Program from 2006-2010 and served as the Chair of the CBCRP council 2008-2009. From 2013 to 2021, he was a member of the Stanford Medicine Alumni Association Board of Governors and served as chair of the Awards Committee during that time. Klaus has been a docent at Stanford's Jasper Ridge Biological Preserve since 2018.
PROFESSIONAL EDUCATION
B.A., Stanford University, Biology “With Great Distinction” and “Departmental Honors” (1969)
M.D., Stanford University School of Medicine (1973)
POSTGRADUATE TRAINING
Internship: Internal Medicine, University of California, San Francisco (1973-74)
Residency: Internal Medicine, Stanford (1974-75)
Research Fellowship: Laboratory of Cellular and Molecular Biology, National Cancer Institute, NIH (1976-78)
Clinical Fellowship: Medical Oncology, Stanford University (1975-76, 1978-79)
ACADEMIC HONORS AND AWARDS
Phi Beta Kappa (1968)
Alpha Omega Alpha (1972)
Winslow J. Cutting Book Award for research in Pharmacology, Stanford (1973)
Russel V. Lee Clinical Teaching Award for Excellence in Clinical Teaching, Medicine, Stanford (1994,1997,1999, and 2000)
Thomas E. Davis Award for Clinical Teaching, Oncology, Stanford (1995)
Honorary Lifetime Medical Staff, Stanford University Hospital (2013) -
Lisa Post
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. Lisa Post, Ph.D. is a licensed clinical psychologist specializing in the treatment of anxiety, depression and adjustment disorders in adults. She has been a practicing clinician at Stanford Hospital and Clinics since 1993. Since 2000, she has been Director of a clinical program for Stanford Varsity Athletes and for nine years has been the Team Clinician for the San Francisco 49ers. Her primary interest are in the treatment of high performing individuals and in stress management.
-
Anna Postolova, MD, MPH
Affiliate, Medicine - Med/Immunology & Rheumatology
BioDr. Postolova is board certified in internal medicine, allergy/immunology, and rheumatology. She cares for patients of all ages with compromised immune systems or allergic conditions including eczema, hives, angioedema, food and drug allergy, allergic rhinitis, asthma, and chronic rhinosinusitis.
She has authored papers and spoken on care for patients with an overlap of autoimmunity and immunodeficiency and conditions like lupus, rheumatoid arthritis, myositis, vasculitis, granulomatous mastitis, and osteoarthritis.
As a native Russian speaker, Dr. Postolova is sensitive to the cultural differences of patients and their families.
